Siemens Medical Solutions announced that it has been granted an Investigational New Drug (IND) Exemption by the FDA to conduct a Phase I clinical trial of (F-18) 3′-fluoro-3′-deoxythymidine (FLT), a molecular imaging biomarker that has shown promise in monitoring the proliferation of cancer cells, which could help physicians quickly determine the effectiveness of cancer therapies.
Read More
HTRF KinEase Combines monoclonal antibody with HTRF technology Cisbio International, Céze, France, a global developer of HTRF technology and services used in assay development and drug screening, launches HTRF KinEASE TK, a universal, sensi
Read MoreTMC125 (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a safe, effective, and well-tolerated treatment for HIV-infected patients with resistance to other NNRTIs, according to two reports in the July 7th issue of The Lancet.
Read More
8-Strip Multiply-µStripPro PCR tubes with individually attached caps Sarstedt Inc, Newton, NC, has announced enhancements to its line of 8-strip Multiply-µStripPro PCR tubes with individually attached caps. Flat-cap versions are now available
Read More
New respiratory tests help detect infections, from infant pneumonia to TB.
Read More